Results 91 to 100 of about 22,892 (185)

The Comparison of Acute Normovolemic Hemodilution with Allogenic Blood Transfusion in Patients who Underwent Femoral Fracture Surgery

Archives of Anesthesia and Critical Care, 2015
Background: Acute normovolemic hemodilution is an available technique to decrease the side effects of allogenic blood transfusion. The aim of this study was to compare acute normovolemic hemodilution with allogenic blood transfusion in adult patients who
Ebrahim Khoshraftar, Hassan Mohammadi Poor Anvari, Mohammad Hossein Bakhshaei, Nahid Manouchehrian, Mohammad Sadegh Sanie Jahromi   +4 more
doaj  

Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion‐Dependent β‐Thalassemia

American Journal of Hematology, Volume 101, Issue 8, Page 1969-1979, August 2026.
ABSTRACT Exagamglogene autotemcel (exa‐cel) is a one‐time, ex vivo, CRISPR‐Cas9 gene edited cell therapy approved for patients with transfusion dependent β‐thalassemia (TDT) aged 12–35 years. In a Phase 3 study (CLIMB THAL‐111), exa‐cel treatment resulted in reactivation of fetal hemoglobin and increases in total hemoglobin, leading to transfusion ...
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, Mattia Algeri, Joachim Rupprecht, Kevin H. M. Kuo, Ami J. Shah, Peter Lang, Hayley Merkeley, Ben Carpenter, Markus Y. Mapara, Robert I. Liem, Stephan Grupp, Yogi Chopra, Amanda M. Li, Janet L. Kwiatkowski, Melanie Kirby‐Allen, Maria Domenica Cappellini, Antonis Kattamis, Sakellarios Zairis, Tina Liu, William Hobbs, Haydar Frangoul, Franco Locatelli, Roland Meisel, on behalf of the CLIMB THAL‐111 and CLIMB‐131 Study Groups   +25 more
wiley   +1 more source

Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Bruton tyrosine kinase inhibitors are central to the treatment of relapsed or refractory mantle cell lymphoma, but cardiovascular and bleeding toxicities influence treatment selection. Ibrutinib has been associated with atrial fibrillation/flutter and other cardiovascular adverse events, whereas second‐generation covalent BTK ...
Anna Homeniuk, Amrit Sandhu, Leena Abdalla, Anas Atrash   +3 more
wiley   +1 more source

THE PORTION OF AUTOLOGOUS BLOOD IN ORTHOPEDIC DEPARTMENT OF GENERAL HOSPITAL NOVA GORICA IN FIVE YEARS PERIOD (1996–2000)

Zdravniški Vestnik, 2002
Background. The presentation of autologous blood donation with analysis of used blood and the percentage of autologous blood on Orthopedic Department in the years 1996–2000.Methods.
Janka Černe-Zavadlav, Željko Mihelič, Albin Plahuta   +2 more
doaj  

Unique One‐Stage Procedure: Simultaneous Patent Foramen Ovale Closure and Resection of Wilms Tumor With Vena Cava Thrombus in a 5‐Year‐Old

Clinical Case Reports, Volume 14, Issue 8, August 2026.
Combined cardiac and abdominal surgery in a child with nephroblastoma, inferior vena cava tumor thrombus extending to the right atrium, and patent foramen ovale. ABSTRACT Wilms tumor with intravascular extension poses significant surgical challenges, particularly when combined with a patent foramen ovale, which adds the risk of paradoxical embolism. We
Lea‐Kathrin Hammer, Tsvetomir Loukanov, Patrick Günther, Mina Farag, Angela‐Maria Czundel, Berthold Klein, Markus Kessler, Christoph W. Michalski, Juri Fuchs   +8 more
wiley   +1 more source

The importance of autologous blood transfusion in lung transplantation and cardiovascular surgeries. [PDF]

Turk Gogus Kalp Damar Cerrahisi Derg, 2021
Akçam Tİ, Özdil A, Kavurmacı Ö, Öztürk P, Başaran DC, Çalkavur İT, Çağırıcı U, Özbaran M.   +7 more
europepmc   +1 more source

Tumor‐infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions

Cancer, Volume 132, Issue 15, 1 August 2026.
Abstract In the past 15 years, immunotherapy has become a major strategy for cancer therapy. Tumor‐infiltrating lymphocyte (TIL) therapy has been under investigation for nearly four decades and received its first Food and Drug Administration approval in 2024, when lifileucel was approved for patients with previously treated metastatic melanoma.
Shen Li, Alexandra E. Rojek, Reid Shaw, Cristina O’Donoghue, J. Michael Millis, Daniel J. Olson   +5 more
wiley   +1 more source

Temperature Safeguards and Peri‐Procedural Strategies for Stem Cell Collection in Cold Agglutinin Disease: A Case Report and Literature Review

Journal of Clinical Apheresis, Volume 41, Issue 4, August 2026.
ABSTRACT Cold agglutinins can result in red blood cell (RBC) agglutination and lysis at low temperatures. Temperature sensitivity during stem cell mobilization, processing, and infusion poses unique procedural challenges in patients with active cold agglutinins.
S. Bellegarde, C. Scott, R. Sabol, T. Eunson, Z. J. Gahvari, C. P. Onyenekwu   +5 more
wiley   +1 more source

Immune Effector Cell‐Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene‐Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell Boosting

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Pancytopenia accompanied by chimeric antigen receptor T cell (CAR‐T) therapy is termed immune effector cell‐associated hematopoietic toxicity (ICAHT), which is often sustained and refractory to supportive care. We report a case of a 52‐year‐old man with multiple myeloma who developed severe ICAHT with secondary myelofibrosis (sMF) after ...
Keishi Ogura, Takahiro Fujino, Takahisa Nakamura, Akihiro Miyashita, Akio Onishi, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Shinichi Fuchida, Junya Kuroda   +9 more
wiley   +1 more source

Immune profiling shows limited systemic changes in children with autism after autologous cord blood transfusion

Frontiers in Immunology
IntroductionAutism spectrum disorder (ASD or autism) is a neurodevelopmental condition characterized by social difficulties and restricted, repetitive behaviors, and is a leading cause of morbidity in children and adolescents.
Yik-Lam Cho, Yik-Lam Cho, Yik-Lam Cho, Zoe Mei Yun Tay, Nicholas Kim Huat Khoo, Nicholas Kim Huat Khoo, Rachel Meau Yenn Cheong, Rachel Meau Yenn Cheong, Rachel Meau Yenn Cheong, Su Li Poh, Judith Ju Ming Wong, Judith Ju Ming Wong, Judith Ju Ming Wong, Judith Ju Ming Wong, Katherine Nay Yaung, Martin Wasser, Martin Wasser, Salvatore Albani, Salvatore Albani, Salvatore Albani, Salvatore Albani, Joyce Ching Mei Lam, Joyce Ching Mei Lam, Joyce Ching Mei Lam, Joyce Ching Mei Lam, Joyce Ching Mei Lam, Chui Mae Wong, Chui Mae Wong, Chui Mae Wong, Chui Mae Wong, Chui Mae Wong, Joo Guan Yeo, Joo Guan Yeo, Joo Guan Yeo, Joo Guan Yeo   +34 more
doaj   +1 more source